FESCA acts at a pan-European level to promote and achieve its objectives in alignment with the aims of the national groups it represents. As an umbrella group, FESCA supports its member organizations, while the support of individual sufferers of scleroderma remains the sole remit of national organizations.
FESCA's objectives include encouraging the active involvement of politicians and pharmaceutical companies, working with doctors to secure earlier diagnosis and better treatments, and creating greater awareness of scleroderma so that those who suffer from it can access proper, equitable care. To do this, FESCA facilitates collaboration among national associations to share ideas and projects, and works towards the evolution of a political, social, and medical enviroment that facilitates the achievement of the FESCA vision.
Please click below for your language:
What is a clinical trial?
The 3rd systemic sclerosis world congress will be held in Rome, on February 6-8, 2014.
The Scleroderma Society of Canada, together with the Scleroderma Society of Ontario, is pleased to announce that the 2013 Scleroderma Canada Congress is coming to Hamilton, On
This is how Scleroderma Society, U.K. will celebrate Scleroderma Day
This is how Ireland will celebrate Scleroderma Day:
Scleroderma Day will be celebrated across Europe, Australia, the USA, Brazil and other countries in order to raise awareness for the scleroderma and for people with scleroderma.
For Scleroderma Day AILS is organising an Open Day for early diagnosis, at Gaetano Pini Hospital, in Milan and at the hospitals Sandro Pertini Hospital and Policlinico Umberto I Hospital